Scientists Restore Sleep in Mice with Alzheimer's

Researchers have found that overactive immune cells in the brain contribute to sleep loss in Alzheimer's disease. Temporarily removing these cells in mice restored more than two hours of sleep per day.
Researchers have made a discovery about sleep loss in Alzheimer's disease. They found that the brain's own immune cells play a role in the sleep disturbances associated with the condition. In mice with amyloid plaques, overactive microglia triggered inflammation that disrupted deep, restorative sleep. This inflammation kept the brain from getting enough sleep. The researchers then temporarily removed most of these microglia cells from the mice. As a result, the mice got more than two hours of additional sleep per day. Notably, the amyloid plaques in the mice remained unchanged, suggesting that the sleep restoration was not due to the removal of the plaques themselves. The study's findings provide new insights into the relationship between immune cells, inflammation, and sleep in Alzheimer's disease. The discovery could potentially lead to new treatments for sleep disturbances in people with Alzheimer's. The researchers' work highlights the complex interplay between different factors in the development of Alzheimer's symptoms.
Go Deeper
What triggered sleep loss in the mice with Alzheimer's?
Overactive microglia, which are the brain's immune cells, triggered inflammation that disrupted deep, restorative sleep. This inflammation kept the brain from getting enough sleep.
How much sleep was restored in the mice?
More than two hours of sleep per day was restored in the mice after the microglia cells were temporarily removed.
Did the removal of microglia cells affect the amyloid plaques?
No, the amyloid plaques in the mice remained unchanged after the microglia cells were removed. The sleep restoration was not due to the removal of the plaques themselves.
What could this discovery lead to?
The discovery could potentially lead to new treatments for sleep disturbances in people with Alzheimer's disease. It provides new insights into the relationship between immune cells, inflammation, and sleep in Alzheimer's disease.
What is the significance of this study's findings?
The study's findings highlight the complex interplay between different factors in the development of Alzheimer's symptoms. They suggest that targeting immune cells and inflammation could be a new approach to addressing sleep disturbances in Alzheimer's disease.
More health
An Experimental Alzheimer's Drug Showed Stronger Benefit at Two Years, but the Numbers Call for Caution
An experimental drug called diranersen showed hopeful two-year results in a study of people with early Alzheimer's disease, including about a 54 perce
Nov 21health50+Flu Is Spreading Early This Year, and Older Adults Face the Highest Risk
Flu is spreading unusually early this year, and adults 65 and older face the highest risk of being hospitalized. Doctors recommend a stronger flu shot
Nov 20health50+Medicare's Open Enrollment Ends December 7, and Some Costs Will Rise in 2027
Medicare's open enrollment ends December 7, and several costs, including the Part D out-of-pocket cap, are rising in 2027. There is still time to swit
Nov 20